Kargl et al. [36] reported that CD8+ T-cells and neutrophils were inversely associated in NSCLC tumour tissues, and their ratio could predict the outcome of anti-PD-1 monotherapy. This evidence concerns the gene CD8A and non-small cell lung carcinoma.